Capmatinib 200mg Tablets

Capmatinib 200mg is a targeted treatment for advanced non-small cell lung cancer with a MET exon 14 skipping alteration. It is selected through molecular testing of the cancer.
Take morning and evening doses with or without food and swallow the tablets whole. If vomiting occurs after a dose, continue at the next scheduled time rather than replacing that dose.
Capmatinib inhibits the MET receptor's kinase activity, interrupting growth and survival signals in susceptible tumour cells.
Swelling, nausea, vomiting, tiredness and reduced appetite can occur. Lung inflammation, liver injury and pancreatic enzyme abnormalities are important risks.
Liver and pancreatic blood tests are monitored. New breathlessness, a worsening cough or jaundice needs prompt assessment, and sun protection helps reduce photosensitivity.
Can shrink or slow the progression of lung cancers driven by the relevant MET alteration.
The treatment is intended for cancers driven by a specific MET alteration rather than all lung cancers.
Not always. Fluid-related swelling is a recognised effect of capmatinib, but new or severe swelling still needs assessment.
Yes. Limiting ultraviolet exposure and using sun protection helps reduce this effect.
No. An additional replacement dose can increase exposure; resume at the next scheduled time.
MET: a growth-signalling receptor. Exon 14 skipping: a genetic alteration that can activate MET. Kinase inhibitor: a medicine blocking enzyme-driven cell signals.; AR: Capmatinib 200mg أقراص; FR: Capmatinib 200mg comprimés; PT: Capmatinib 200mg comprimidos; ES: Capmatinib 200mg comprimidos; RU: Capmatinib 200mg таблетки; ID: Capmatinib 200mg tablet; VI: Capmatinib 200mg viên nén; MS: Capmatinib 200mg tablet; TL: Capmatinib 200mg mga tableta; ZH-SG: Capmatinib 200mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Capmatinib 200mg Tablets under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Capmatinib 200mg Tablets